Nureca promoter stake hits 68.09% after FSA in 2026

What Nureca disclosed and why it matters

Nureca Limited has reported a significant internal reshuffle within its promoter group after a Family Settlement Agreement (FSA). The company said promoter Saurabh Goyal acquired shares through an off-market inter se transfer, which materially increased his individual voting rights. The shift is accompanied by a leadership change, with CEO Aryan Goyal set to step down and resign as a director.

While the headline number is a jump in Saurabh Goyal’s voting rights to 68.09%, the company’s messaging is that this is a promoter-level realignment rather than a fresh acquisition of control. Such disclosures matter to investors because they change who holds voting power, clarify succession and management continuity, and can trigger compliance steps under SEBI takeover regulations.

Family Settlement Agreement signed on June 17, 2026

Nureca announced that promoter group members entered into a Family Settlement Agreement dated June 17, 2026. Under the FSA, Aryan Goyal and his wife, Payal Goyal, will transfer all their shares in the company to Saurabh Goyal.

The agreement also includes a management change. As disclosed by the company, Aryan Goyal will resign as CEO and also step down as a director. After the transfers, Saurabh Goyal is described as the Chairman and Managing Director and the sole promoter, with his individual voting rights increasing substantially.

Off-market inter se transfer completed on July 2, 2026

As part of the promoter reorganisation, Saurabh Goyal acquired 32,19,113 equity shares of Nureca Limited through an off-market inter se transfer on July 2, 2026. The company linked this transfer to the Family Settlement Agreement.

Following the transaction, his total shareholding rose to 64,97,169 equity shares, representing 68.09% of the paid-up capital. Prior to this transfer, Saurabh Goyal held 32,78,056 equity shares, which accounted for 34.35% of the paid-up share capital.

The disclosure frames the transaction as a transfer among promoter group members, rather than a market purchase. In such cases, the key investor takeaway is that the shareholding is being consolidated within the promoter family group and not being bought from public shareholders.

How the shareholding changed across the promoter group

The company provided a detailed before-and-after snapshot of shareholding and voting rights. It shows that Payal Goyal and Aryan Goyal move to zero shareholding post-transfer, while the public shareholding remains unchanged at 31.91%.

Shareholding and voting rights: pre and post transfer

This table indicates that the paid-up equity base is 95,41,920 shares and that the transfer reshuffles holdings within promoters without changing public ownership percentage.

CEO and board change: Aryan Goyal to resign

Alongside the share transfer, the company disclosed that Aryan Goyal will step down as CEO and resign as a director. This is a notable governance development because it changes both management responsibility and board composition.

From the disclosure, the intended outcome is a single-point promoter leadership structure centred on Saurabh Goyal as Chairman and Managing Director. For shareholders, the immediate practical implication is that executive leadership will change hands, and the company will need to update regulatory filings and corporate governance records accordingly.

SEBI takeover rules: company seeking exemption

Nureca stated it is seeking an exemption from takeover regulations for this internal promoter transfer. The basis cited in the disclosure is Regulation 10(1)(a), and the company positioned the transaction as an internal promoter transfer linked to a family settlement.

In the same context, Nureca stated that this is “no fresh control acquisition.” The distinction is relevant because takeover regulations typically focus on changes in control and thresholds that can trigger open offer obligations.

Related promoter transfer earlier in June 2026

Separately, Nureca also disclosed a promoter group inter se transfer involving Nectar Biopharma Private Limited. Nectar Biopharma Private Limited transferred 60,842 equity shares to promoter Saurabh Goyal on June 09, 2026, for a total consideration of ₹1,43,70,880 (₹1.44 crore).

The company stated that this June 09 transaction was an internal realignment and did not impact the aggregate promoter and promoter group holding, which remained at 68.09%. The shareholding table in that disclosure showed Saurabh Goyal’s holding rising from 33.72% (32,17,214 shares) to 34.35% (32,78,056 shares), while Aryan Goyal’s holding remained unchanged at 12.15% (11,59,185 shares) for that specific event.

Background: buyback effect on promoter group percentage

Nureca has also previously linked promoter holding percentage changes to its buyback. The company disclosed that its buyback commenced on December 18, 2025 and concluded on December 24, 2025, with extinguishment of shares on January 07, 2026.

As a result, while the total number of shares held by the promoter and promoter group remained 64,97,176, their collective percentage holding rose from 64.97% to 68.09% of the total share capital. The company also listed proportional increases in individual promoter holdings post-buyback, including Saurabh Goyal rising to 33.72% from 32.17%, Payal Goyal to 21.59% from 20.60%, and Aryan Goyal to 12.15% from 11.59%.

Market impact and what investors can track next

The immediate market relevance of this disclosure is centred on ownership concentration and governance continuity. Post-transfer, Saurabh Goyal’s voting rights rise to 68.09%, while the public remains at 31.91%, based on the company’s table.

Investors tracking Nureca can watch for updates on (1) formal resignation and appointment filings linked to the CEO and director change, and (2) SEBI’s response to the exemption request under the takeover regulations framework cited by the company. The company’s disclosures so far emphasise that the transaction is an internal promoter transfer under a family settlement and not positioned as a new control event.

Conclusion

Nureca’s June 2026 family settlement sets up two major changes: consolidation of promoter voting power with Saurabh Goyal at 68.09% and the planned exit of Aryan Goyal as CEO and director. The share transfer was executed off-market on July 2, 2026, and the company has also indicated it is seeking regulatory exemption for the internal promoter transfer. The next set of confirmed developments to watch will be the formal leadership transition and any regulatory decision on the exemption request.